Connect your AI

Vivani Medical VANI Financing Cash Flow

Financing Cash Flow at other companies

Eli LillyLLY

-$3.47B-351%

AmgenAMGN

$1.44B+135%

AltimmuneALT

$78.47M+130%

Viking TherapeuticsVKTX

$12.08M+3,360%

Wave Life SciencesWVE

$2.53M-39.2%

Prime MedicinePRME

$393K-93.5%

Other financials

Income statement

Revenue-—

Gross profit$130.0K—

Operating income-$6.8M-4.0%

Net income-$6.8M-7.6%

EPS (diluted)-$0.08+27.3%

Balance sheet

Cash & equivalents$19.0M+57.7%

Total debt$18.3M-3.5%

Total equity$19.1M+64.2%

Total assets$42.4M+19.5%

Cash flow

Operating cash flow-$6.2M-20.0%

CapEx$3.0K-40.0%

Free cash flow-$6.2M-19.9%

Valuation

Market cap$106.93M+40.0%

Enterprise value$106.17M+19.3%

Profitability

Gross margin36.3%—

Operating margin-1,004.9%—

Net margin-994.1%—

FCF margin-832.3%—

Returns & leverage

Return on equity-176.4%+175pp

Debt / equity1×-0.7×

Current ratio3.2×+0.8×

Where this comes from

Reported directly by Vivani Medical in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The official record: Vivani Medical’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vivani Medical's financing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Vivani Medical's financing cash flow?: Vivani Medical (VANI) reported financing cash flow of $9.71M in Q1 2026.
How has Vivani Medical's financing cash flow changed year-over-year?: Vivani Medical's financing cash flow increased by 5814.1% year-over-year, from -$170K to $9.71M.
What is the long-term trend for Vivani Medical's financing cash flow?: Over 2 years (2022 to 2025), Vivani Medical's financing cash flow has grown at a -39.4% compound annual growth rate (CAGR), from $63.39M to $23.27M.
What does financing cash flow mean?: Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.